Christopher Subasic 31st Lorne Cancer Conference 2019

Abstracts this author is presenting:

• The utility of a HPMA-NIPAM co-polymer as a less-immunogenic alternative to PEGylation as an approach to modify the pharmacokinetic behaviour of antibody therapeutics — Poster Session II
• Sex differences in the plasma pharmacokinetics of Caelyx are not observed in relatively healthy individuals: a study in healthy rats and retrospective evaluation in humans — Poster Session II